The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

11 Jun 2007 12:18

PuriCore Plc11 June 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): PuriCore PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): Newton Investment Management Limited 4. Full name of shareholder(s) (if different from 3.) (iv): Newton Investment Management Limited 5. Date of the transaction and date on which the threshold is crossed or reachedif different) (v): 18/05/07 6. Date on which issuer notified: 22/05/07 7. Threshold(s) that is/are crossed or reached: Decrease from 7.03% to 6.70% 8. Notified details: Sale 500,000 shares A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction (vi) Number of shares Number of voting Rights (viii) Ordinary 10,672,573 7.03%Shares ISINGB00B13TCY87 Resulting situation after the triggering transaction (vii) Class/type of shares Number of shares Number of voting rights % of voting rights if possible using (ix) the ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect Ordinary N/A N/A 10,172,573 N/A 6.70%Shares ISINGB00B13TCY87 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Date Exercise/Conversion Number of voting % of voting financial (xiii) Period/ Date (xiv) rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 10,172,573 6.70% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Newton Investment Management Limited hold these shares as a discretionary Investment Manager. Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: 14. Contact name: Clare Cox / Barry Smalls 15. Contact telephone number: +44(0)207 163 2331 / 2251 Annex Notification Of Major Interests In Shares (XVI) A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities): Newton Investment Management Ltd Contact address (registered office for legal entities): Mellon Financial Centre160 Queen Victoria StreetLondon EC4V 4LA Phone number:+44(0)207 163 9000 Other useful information (at least legal representative for legal persons): Rachel Wheeler B: Identity of the notifier, if applicable (xvii) Full name: Newton Investment Management Ltd Contact address: Mellon Financial Centre160 Queen Victoria StreetLondon EC4V 4LA Phone number: +44(0)207 163 9000 Other useful information (e.g. functional relationship with the person or legalentity subject to the notification obligation): Discretionary Investment Manager C: Additional information : Notes to the Forms (i) This form is to be sent to the issuer or underlying issuer and to be filedwith the competent authority. (ii) Either the full name of the legal entity or another method for identifyingthe issuer or underlying issuer, provided it is reliable and accurate. (iii) This should be the full name of (a) the shareholder; (b) the personacquiring, disposing of or exercising voting rights in the cases provided for inDTR5.2.1 (b) to (h); (c) all the parties to the agreement referred to inDTR5.2.1 (a), or (d) the direct or indirect holder of financial instrumentsentitled to acquire shares already issued to which voting rights are attached,as appropriate. In relation to the transactions referred to in points DTR5.2.1 (b) to (h), thefollowing list is provided as indication of the persons who should be mentioned: - in the circumstances foreseen in DTR5.2.1 (b), the person that acquires thevoting rights and is entitled to exercise them under the agreement and thenatural person or legal entity who is transferring temporarily for considerationthe voting rights; - in the circumstances foreseen in DTR 5.2.1 (c), the person holding thecollateral, provided the person or entity controls the voting rights anddeclares its intention of exercising them, and person lodging the collateralunder these conditions; - in the circumstances foreseen in DTR5.2.1(d), the person who has a lifeinterest in shares if that person is entitled to exercise the voting rightsattached to the shares and the person who is disposing of the voting rights whenthe life interest is created; - in the circumstances foreseen in DTR5.2.1 (e), the parent undertaking and,provided it has a notification duty at an individual level under DTR 5.1, underDTR5.2.1 (a) to (d) or under a combination of any of those situations, thecontrolled undertaking; - in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of theshares, if he can exercise the voting rights attached to the shares depositedwith him at his discretion, and the depositor of the shares allowing the deposittaker to exercise the voting rights at his discretion; - in the circumstances foreseen in DTR5.2.1 (g), the person that controls thevoting rights; - in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he canexercise the voting rights at his discretion, and the shareholder who has givenhis proxy to the proxy holder allowing the latter to exercise the voting rightsat his discretion. (iv) Applicable in the cases provided for in DTR 5.2.1 (b) to (h). This shouldbe the full name of the shareholder who is the counterparty to the naturalperson or legal entity referred to in DTR5.2. (v) The date of the transaction should normally be, in the case of an onexchange transaction, the date on which the matching of orders occurs; in thecase of an off exchange transaction, date of the entering into an agreement. The date on which threshold is crossed should normally be the date on which theacquisition, disposal or possibility to exercise voting rights takes effect (seeDTR 5.1.1R (3)). For passive crossings, the date when the corporate event tookeffect. (vi) Please refer to the situation disclosed in the previous notification, Incase the situation previous to the triggering transaction was below 3%, pleasestate 'below 3%'. (vii) If the holding has fallen below the minimum threshold , the notifyingparty should not be obliged to disclose the extent of the holding, only that thenew holding is less than 3%. For the case provided for in DTR5.2.1(a), there should be no disclosure ofindividual holdings per party to the agreement unless a party individuallycrosses or reaches an Article 9 threshold. This applies upon entering into,introducing changes to or terminating an agreement. (viii) Direct and indirect (ix) In case of combined holdings of shares with voting rights attached 'directholding' and voting rights 'indirect holdings', please split the voting rightsnumber and percentage into the direct and indirect columns-if there is nocombined holdings, please leave the relevant box blank. (x) Voting rights to shares in respect of which the notifying party is a directshareholder (DTR 5.1) (xi) Voting rights held by the notifying party as an indirect shareholder (DTR5.2.1) (xii) If the holding has fallen below the minimum threshold, the notifying partyshould not be obliged to disclose the extent of the holding, only that the newholding is below 3%. (xiii) date of maturity / expiration of the finical instrument i.e. the datewhen the right to acquire shares ends. (xiv) If the financial instrument has such a period-please specify the period-for example once every three months starting from the (date) (xv) The notification should include the name(s) of the controlled undertakingsthrough which the voting rights are held. The notification should also includethe amount of voting rights and the percentage held by each controlledundertaking, insofar as individually the controlled undertaking holds 5% ormore, and insofar as the notification by the parent undertaking is intended tocover the notification obligations of the controlled undertaking. (xvi ) This annex is only to be filed with the competent authority. (xvii) Whenever another person makes the notification on behalf of theshareholder or the natural person/legal entity referred to in DTR5.2 and DTR5.3 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Jul 20087:04 amRNSPuriCore Wins Food Safety Con
30th Jul 20087:02 amRNSTrading Update
30th Jul 20087:00 amRNSPlacing and Open Offer
2nd Jul 20087:00 amRNSAwarded Contract
1st Jul 20087:00 amRNSPatent Decision and Debt Fina
26th Jun 200811:34 amRNSAGM Statement
19th Jun 20087:00 amRNSPiper Jaffray European Confer
9th Jun 20087:00 amRNSNatural Resources & Infrastru
2nd Jun 20087:00 amRNSAnnual Report and Accounts
27th May 20087:00 amRNSAnnual Information Update
20th May 20083:48 pmRNSHolding(s) in Company
14th May 200812:19 pmRNSHolding(s) in Company
13th May 20089:07 amRNSDirector/PDMR Shareholding
1st May 200810:06 amRNSDirector/PDMR Shareholding
30th Apr 20084:01 pmRNSDirector/PDMR Shareholding
29th Apr 20087:01 amRNSInterim Management Statement
29th Apr 20087:01 amRNSFinal Results
23rd Apr 20087:01 amRNSPresent Clinical Data
3rd Apr 20087:00 amRNSNotice of Results
21st Feb 20084:20 pmRNSNotice of Interest in Shares
21st Feb 20087:01 amRNSDirector/PDMR Shareholding
20th Feb 20087:01 amRNSTrading Update
20th Feb 20087:01 amRNSAcquisition Agreement for IP
8th Feb 20082:26 pmRNSHolding(s) in Company
6th Feb 20088:31 amRNSBlocklisting Interim Review
6th Feb 20088:04 amRNSSenior Independent Director
1st Feb 20088:48 amRNSVoting rights
23rd Jan 20087:00 amRNSResearch Update
11th Jan 20087:00 amRNSRe: Food Retail Contract
21st Dec 200711:36 amRNSHolding(s) in Company
10th Dec 20077:01 amRNSAdditional US Patent
23rd Nov 20075:52 pmRNSHolding(s) in Company
25th Oct 200712:00 pmBUSPuriCore Presenting at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
25th Oct 20077:00 amRNSPresenting at Conference
17th Oct 200712:00 pmBUSPuriCore Arranges New $20 Million Borrowing Facility
17th Oct 20077:00 amRNSArranges Borrowing Facility
12th Oct 20078:46 amRNSFCSI Product of the Year
11th Oct 20074:35 pmBUSSterilox Food Safety System Named FCSI Product of the Year
8th Oct 200712:00 pmBUSPuriCore Receives US Patent on Wound Therapy Method
8th Oct 20077:00 amRNSReceives US Patent
24th Sep 20077:03 amRNSRe: Wound Therapy System
24th Sep 20077:01 amRNSInterim Results
5th Sep 20074:14 pmRNSHolding(s) in Company
4th Sep 20077:01 amRNSBlocklisting Applications
31st Aug 20077:01 amRNSBlocklisting Interim Review
24th Jul 20076:24 pmRNSHolding(s) in Company
24th Jul 20079:32 amRNSDirector's Interest
23rd Jul 20077:01 amRNSTrading Update
18th Jun 200712:00 pmBUSAdditional Studies Demonstrate PuriCore's Sterilox Solution Effective against Major Outbreak Pathogens
18th Jun 20077:02 amRNSResearch Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.